Participants 45 84 4
children with autism spectrum disorders
Participants 210 264 7
children with autism spectrum disorders ages 3-8 years
Participants 274 342 5
Phase 1 involved 65 children who received one round of DMSA (3 days)
Participants 344 580 8
Participants who had high urinary excretion of toxic metals were selected to continue on to phase 2. In phase 2, 49 participants were randomly assigned in a double-blind design to receive an additional 6 rounds of either DMSA or placebo
